Yucheng Wu Selected Research

Yucheng Wu Research Topics

Disease

15	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2016
14	Diabetic Nephropathies (Diabetic Nephropathy) 03/2024 - 07/2018
13	Chronic Kidney Failure (Chronic Renal Failure) 02/2023 - 07/2018
12	Proteinuria 12/2023 - 07/2018
6	Fibrosis (Cirrhosis) 12/2023 - 01/2019
6	Atrophy 12/2023 - 01/2019
6	Inflammation (Inflammations) 01/2023 - 06/2019
5	Hypertension (High Blood Pressure) 01/2022 - 01/2019
5	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2020 - 07/2018
4	Chronic Renal Insufficiency 04/2023 - 01/2019
2	Heart Failure 04/2023 - 10/2020
2	Body Weight (Weight, Body) 01/2023 - 08/2015
2	Atrial Fibrillation 01/2022 - 01/2022
2	Insulin Resistance 12/2021 - 01/2016
1	Leg Ulcer 04/2024
1	Albuminuria 01/2024
1	Obesity 01/2023
1	Metabolically Benign Obesity 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Hyperglycemia 01/2023
1	AIDS-Related Complex (ARC) 09/2022
1	Stroke (Strokes) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021
1	Latent Autoimmune Diabetes in Adults 12/2021
1	Hypotension (Low Blood Pressure) 10/2020
1	Hypoxia (Hypoxemia) 07/2020
1	Bundle-Branch Block (Fascicular Block) 01/2020
1	Diabetes Mellitus 06/2019
1	Anemia 06/2019
1	Neoplasms (Cancer) 01/2019
1	Conversion Disorder (Astasia Abasia) 08/2018
1	Renal Insufficiency (Renal Failure) 07/2018
1	Stomach Neoplasms (Stomach Cancer) 03/2016
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Reperfusion Injury 06/2013
1	Brain Ischemia (Cerebral Ischemia) 06/2013

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 01/2016
5	Serum AlbuminIBA 02/2023 - 01/2019
5	Hemoglobins (Hemoglobin)IBA 02/2023 - 04/2020
5	CholesterolIBA 01/2023 - 04/2020
3	AlbuminsIBA 01/2024 - 01/2022
3	LipidsIBA 01/2023 - 01/2022
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2019 - 01/2019
3	GoldIBA 03/2016 - 06/2013
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2023 - 12/2021
2	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2020
2	CreatinineIBA 01/2023 - 01/2019
2	Uric Acid (Urate)IBA 01/2022 - 10/2021
2	Insulin (Novolin)FDA Link 01/2022 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2020
2	IncretinsIBA 12/2021 - 10/2020
2	Fibrinogen (Factor I)FDA Link 11/2019 - 07/2018
1	DNA (Deoxyribonucleic Acid)IBA 03/2024
1	HDL CholesterolIBA 01/2024
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023
1	pro-brain natriuretic peptide (1-76)IBA 12/2023
1	Endothelin Receptor AntagonistsIBA 04/2023
1	pirfenidoneIBA 04/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2023
1	Pentoxifylline (Trental)FDA LinkGeneric 04/2023
1	SodiumIBA 04/2023
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2023
1	Dipeptidyl-Peptidase IV InhibitorsIBA 04/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	Liraglutide FDA Link 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	AlloysIBA 09/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	C-PeptideIBA 12/2021
1	Indicators and Reagents (Reagents)IBA 12/2021
1	C-Reactive ProteinIBA 10/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2020
1	tungsten oxideIBA 07/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020
1	hydroxide ionIBA 01/2020
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 08/2019
1	Complement C3 (C3 Complement)IBA 08/2019
1	BilirubinIBA 06/2019
1	Heme Oxygenase-1IBA 06/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	CR 39 (CR39)IBA 01/2019
1	Cystatin CIBA 01/2019
1	LithiumIBA 08/2018
1	Oxygen (Dioxygen)IBA 08/2018
1	Interleukin-1 Type I ReceptorsIBA 01/2015
1	Citric Acid (Citrate)FDA LinkGeneric 06/2013

Therapy/Procedure

9	Therapeutics 01/2022 - 06/2013
2	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2019 - 01/2019
2	Aftercare (After-Treatment) 03/2016 - 01/2014
1	Magnetic Field Therapy 04/2024
1	Radiofrequency Ablation 01/2022
1	Cardiac Rehabilitation 01/2022
1	Cardiac Resynchronization Therapy 01/2020
1	Electrodes (Electrode) 08/2018